An oral carbon monoxide-releasing molecule protects against acute hyperhemolysis in sickle cell disease. Nguyen KA, Matte A, Foresti R, Federti E, et al. Blood 2024;143:2544-2558.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nguyen KA, Matte A, Foresti R, Federti E, et al. An oral carbon monoxide-releasing molecule protects against acute hyperhemolysis in sickle cell disease. Blood 2024;143:2544-2558.
PMID: 38518106